Healthtech Startups

Promentis Pharmaceuticals is a privately-held biopharmaceutical company developing oral compounds targeting the System xc- glutamate pathway to treat neuropsychiatric disorders. Its lead indication is trichotillomania, and its work extends to other obsessive-compulsive, addictive, and CNS conditions.

2 investors

Reve is an AI revenue cycle management platform for hospitals and healthcare providers that validates claims before submission, audits payments, and manages denials to reduce denied and underpaid insurance claims. Built by former health insurance system designers, it covers the claim lifecycle from pre-surgery authorization checks through post-payment audit.

2 investors

Prosoria is an over-the-counter consumer healthcare company that develops pharmaceutical-grade products for chronic health conditions using scientifically-tested formulations. The company focuses on creating safer and more effective alternatives to traditional treatments, serving customers seeking improved quality of life through better health solutions.

2 investors

Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.

2 investors

Proteina develops single-molecule protein-protein interaction (PPI) detection technology (SPID) that generates real-time, high-resolution data to support therapeutic drug development. The company applies PPI analysis toward precision medicine.

2 investors

Protembis is a German medical device company developing the ProtEmbo Cerebral Protection System, an intra-aortic filter device inserted via the left radial artery that shields the brain from embolic debris during transcatheter aortic valve replacement (TAVR) and other left-sided heart procedures. The device aims to reduce the risk of stroke and cognitive decline for cardiac patients and is undergoing clinical investigation.

2 investors

ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence. Its work spans ex vivo cell therapy (ProT-096) and in vivo biologic programs (RGT-096).

2 investors

Prothea Technologies develops fluorescence imaging and optical sensing technologies for respiratory medicine and oncology applications. The company creates medical devices and diagnostic platforms focused on advancing clinical validation and regulatory approval for respiratory and cancer care.

2 investors

ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH). Founded in 2016, it is headquartered in Dublin, Ireland with a manufacturing facility in Galway and team members in the USA.

2 investors

ProviderTrust provides automated exclusion list monitoring to healthcare organizations to identify excluded individuals and entities from federal and state databases. The solution continuously screens employees, physicians, and vendors against multiple government exclusion lists to prevent fraud, waste, and abuse in healthcare operations.

2 investors

Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.

2 investors

Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use. The company serves researchers, physicians, and healthcare systems working within regulated compassionate-use and special access programs.

2 investors

Puffpaw manufactures smart vapes with Bluetooth connectivity that track vaping activity and reward users with cryptocurrency tokens for reducing nicotine intake. The device uses an encrypted chip to store verifiable on-chain data and gamifies the experience of quitting nicotine addiction.

2 investors

Pulsatile Innovations develops Pulse Tile, a medical device focused on emergency cardiac care, particularly cardiac arrest. The company pursues TGA compliance and a Class IIb regulatory pathway for its healthcare technology in Australia.

2 investors

PulseSight Therapeutics develops non-viral, plasmid-based gene therapies delivered via a proprietary electro-transfection system into the ciliary muscle to treat severe retinal diseases causing blindness. Its lead programs target late-stage dry AMD/geographic atrophy and wet AMD, with prior Phase 1/2 studies conducted in Europe and the USA.

2 investors

Pupilmed is a veterinary clinic offering internal medicine visits, vaccinations, deworming, specialist consultations, and emergency care for dogs and cats. It provides an online patient panel for tracking visit history and test results, free adaptation visits to reduce animal stress, and holistic care including behavioral and dietary support.

2 investors

Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform. The company focuses on preserving kidney function in patients with large, underserved populations affected by renal disease.

2 investors

PurposeMed is a physician-led telehealth company that builds branded services connecting patients with specialist clinicians for remote care, including PrEP, adult ADHD diagnosis and treatment, and gender-affirming care and hormone therapy. It serves underserved communities in Canada and the USA, integrating with the public healthcare system and offering affiliated pharmacy delivery.

2 investors

Pykus Therapeutics is a clinical-stage medical technology company developing biodegradable polymers for vitreoretinal surgery. Its lead product, PYK-2101, is a biodegradable hydrogel intended to help patients recover from retina surgery faster and more comfortably.

2 investors

2 investors

QbDVision provides a software platform designed to address digital transformation challenges in pharmaceutical and biotech manufacturing, helping companies manage compliance, quality, and process development.

2 investors

Qoniq provides data analysis and knowledge synthesis tools for Medical and Scientific Affairs professionals, helping them work with complex scientific datasets while augmenting rather than replacing human expertise.

2 investors

Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.

2 investors

Quadrant Eye develops at-home diagnostic technology to conduct comprehensive eye examinations. The platform aims to increase access to eye care services and help prevent avoidable vision loss.

2 investors